HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.16
Day range
$0.13 - $0.16
Year range
$0.075 - $0.40
Market cap
7.87M CAD
Avg Volume
33.29K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 252.83K | 13.59% |
Net income | -342.26K | -23.01% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 633.54K | 660.66% |
Total assets | 683.06K | 198.74% |
Total liabilities | 4.33M | 30.91% |
Total equity | -3.65M | — |
Shares outstanding | 58.00M | — |
Price to book | -2.58 | — |
Return on assets | -125.19% | — |
Return on capital | 41.61% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -342.26K | -23.01% |
Cash from operations | -178.46K | 32.01% |
Cash from investing | — | — |
Cash from financing | 683.14K | — |
Net change in cash | 504.68K | 292.27% |
Free cash flow | -29.46K | 79.78% |
About
Founded
2021
Headquarters
Website
